To participate in research on ALZHEIMER'S DISEASE
at the Stanford / VA Alzheimer Center, click here!!
MEDAFILE is a website on ALZHEIMER'S DISEASE - for
families, clinicians, researchers - providing
information on Alzheimer's disease, forms for medical practitioners
to evaluate patients with dementia or other memory problems,
diagnostic recommendations, management suggestions, and etiological
International Conference on Alzheimer's Disease - July 17, 2006, Madrid, Spain
Poster: "DEMENTIA SCREEENING: IMPLICATIONS OF AGE, APOE GENOTYPE, PHARMACOECONOMIC FACTORS "
See Dr. Ashford talk about Alzheimer's disease in San Francisco (2002)
(about 1 meg, WMV format, Active X). This video clip
introduces the End Alzheimer
Task Force of the Internet
Broadcasting Association and plans for
on-line Alzheimer screening tests.
CLINICAL EVALUATION FORMS AVAILABLE:
- A-Screen is a test that is recommended for primary care practitioners
to screen patients over the age of 60 years for possible cognitive
impairment. - The standard MMSE, as a group of items to
be arithmetically summed (removed pending resolution of copyright issues),
is not recommended
by this site. Note that there have been recent attempts to pull
this test from the public domain by the new owners of the copyright, who
have also obtained a trademark for this widely used term. As a clear
public domain alternative, the Stanford / VA Alzheimer Center has developed
the Brief Cognitive Exam (removed pending resolution of copyright issues).
A better approach to dementia severity measurement is to complete the
"Item Response Analysis" version of the MMSE, provided here, and
calculate an estimate of the relative number of years into Alzheimer's
MMSEi. The extended version,
MMSEe, provides a broader assessment.
TOP 10 TREATMENTS for preventing
version in Long Island Alzheimer Foundation News Letter, July, 2002
-- see - 2008 version web
-- see - 2008 version doc
ALZHEIMER HYPOTHESIS (Dr. Ashford's
Dr. Ashford's comment on the NIH State-of-the-Science Conference, April 26-28, 2010
(This conference downplayed important developments in research on risk factors, particularly genetics, and prevention of Alzheimer's disease, while recommending RCTs - randomized controlled trials - before we even know what to test.)